KPIs & Operating Metrics(New)

Gsk (GSK) Assets Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.97%
Dec 31, 2025 4.84%
Sep 30, 2025 5.20%
Jun 30, 2025 -11.00%
Mar 31, 2025 8.17%
Dec 31, 2024 -10.55%
Sep 30, 2024 -11.41%
Jun 30, 2024 -12.02%
Mar 31, 2024 -11.66%
Dec 31, 2023 -11.65%
Jun 30, 2023 -10.87%
Mar 31, 2023 -13.00%
Dec 31, 2022 -11.70%
Sep 30, 2022 -11.53%
Jun 30, 2022 11.06%
Mar 31, 2022 -9.38%
Dec 31, 2021 12.59%
Sep 30, 2021 12.40%
Jun 30, 2021 11.09%
Mar 31, 2021 11.29%
Dec 31, 2020 12.37%
Jun 30, 2020 12.20%
Mar 31, 2020 13.81%
Dec 31, 2019 11.73%
Sep 30, 2019 9.93%
Jun 30, 2019 -0.37%
Mar 31, 2019 1.31%
Dec 31, 2018 -2.70%
Sep 30, 2018 -3.18%
Jun 30, 2018 -1.99%
Mar 31, 2018 -3.88%
Dec 31, 2017 5.14%
Sep 30, 2017 4.52%
Jun 30, 2017 4.41%
Mar 31, 2017 3.75%
Dec 31, 2016 2.53%
Sep 30, 2016 6.64%
Jun 30, 2016 8.61%
Mar 31, 2016 5.40%
Dec 31, 2015 178.22%
Sep 30, 2015 9.62%
Jun 30, 2015 7.45%
Mar 31, 2015 11.12%
Dec 31, 2014 157.23%
Sep 30, 2014 0.34%
Jun 30, 2014 -1.60%
Mar 31, 2014 -1.23%
Dec 31, 2013 0.71%
Sep 30, 2013 -1.23%
Jun 30, 2013 0.17%
Mar 31, 2013 -1.39%
Dec 31, 2012 -62.25%
Sep 30, 2012 -2.06%
Jun 30, 2012 6.49%
Mar 31, 2012 4.44%